SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

OncoHost to Present Plasma Proteomics Research at ISLB 2026

The research concerns early detection of immunotherapy resistance; new data indicates longitudinal plasma proteomics may detect disease progression.

Related stories